Navigation Links
An underwater drugstore?
Date:2/26/2009

No matter how sophisticated modern medicine becomes, common ailments like fungal infections can outrun the best of the world's antibiotics. In people with compromised immune systems (like premature babies, AIDS victims or those undergoing chemotherapy for cancer) the risk is very high: contracting a fungal infection can be deadly.

Now Tel Aviv University zoologists are diving deep into the sea to collect unique chemicals drugs of the future to beat unnecessary death by fungal infection. And their secret weapon is the common marine sponge.

Prof. Micha Ilan from the Department of Zoology at Tel Aviv University, who is heading the project, has already identified several alternative antibiotic candidates among the unique compounds that help a sponge fend off predators and infections. He and his graduate students are now identifying, isolating and purifying those that could be the super-antibiotics of the future.

The research group at TAU has found and isolated thousands bacteria and fungi, including a few hundred unique actinobacteria. So far, several tens hold promise as new drugs.

From the Sea to the Lab

"Resistance to antibiotics has become an unbelievably difficult challenge for the medical community," says Prof. Ilan. "Sponges are known for hosting an arsenal of compounds that could work to fight infections. We're now culturing huge amounts of microorganisms, such as actinobacteria, that live in symbiosis with marine sponges."

Marine sponges were recently made famous by the popular Nickelodeon TV cartoon SpongeBob SquarePants, which features a sea sponge who lives in a pineapple beneath the ocean. In real life, sea sponges are animals whose bodies consist of an outer thin layer of cells and an inner mass of cells and skeletal elements. The sedentary creatures don't really have the sort of adventurous life that the cartoon depicts.

Marine sponges can't move. Glued to the seafloor, they must rely on the flow of water through their bodies to collect food and to remove waste. This has led to a unique adaptive response to enemies and competition. Sponges don't have teeth, or shells, but protect themselves by building associations and partnerships with bacteria and fungi. Tel Aviv University is tapping into these relationships looking at the same chemicals that the sponge uses for defense to fight infection in humans.

Research Combines Several Fields of Study

Drug developers have known for decades about the potential goldmine of pharmaceuticals in the marine environment, particularly among sedentary life like marine sponges.

"One of the major problems is that these novel and natural compounds are found in very small quantities," Prof. Ilan explains. Collecting and extracting such large amounts of these unique chemicals would require huge quantities of animals to be sacrificed, a practice which is not in line with zoological conservationist values. So Prof. Ilan takes cultures from sea sponges with minimal damage to the natural environment. He then grows their symbionts and tests them in a "wet" laboratory. The methods Prof. Ilan has perfected can now be used by other scientists developing pharmaceuticals from marine sponges.

"Our research is unique in that we take both an agricultural and microbiological approach ― not found often in the drug discovery community," says Prof. Ilan, whose work is done in collaboration with the School of Chemistry's Prof. Yoel Kashman and Prof. Shmuel Carmeli.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Related biology news :

1. Unveiling the underwater ways of the white shark
2. Underwater microscope helps prevent shellfish poisoning along Gulf Coast of Texas
3. School of Robofish provides basis for underwater robot teams
4. NJIT professors research suggests changes in underwater data communications
5. Little Salt Spring underwater archeological site in Florida receives new funding
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
An underwater drugstore?
(Date:1/20/2016)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce the attainment of record-setting ... result of the company,s laser focus on (and growing ... it,s comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... MedNet growth achievements in 2015 include: , ...
(Date:1/15/2016)... Rico , Jan. 15, 2016 Recent ... and small to find new ways to ensure data ... iOS and Android that ... on biometrics, transforming it into a hardware authorization token. ... users swipe their fingerprint on their KodeKey enabled device ...
(Date:1/11/2016)... Synaptics Incorporated (NASDAQ: SYNA ), the ... its ClearPad ® TouchView ™ 4300 touch ... categories in the 8 th Annual Mobile Excellence ... The Synaptics ® TDDI solution enables faster time-to-market, ... devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... fostering and monetization of intellectual property, today provided an ... in the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings ... Office.  The IPR was initiated on only certain claims ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
(Date:2/3/2016)... BRUNSWICK, N.J. , Feb. 3, 2016 /PRNewswire-USNewswire/ ... grants totaling more than $1 million for researchers ... are working on health-related research that demonstrates exciting ... this round of funding for the New Jersey ... for faculty members at these educational institutions— Princeton ...
(Date:2/3/2016)... -- Silk Therapeutics, Inc., today announced the closing of a $6 ... a total of $10.25 million in Series A funding based ... round was led by existing investor The Kraft Group of ... investors Lear Corporation and Highland Consumer Partners, as well as ... Richard Sackler , MD, with Summer Road, LLC; Erin ...
Breaking Biology Technology: